William C. Sessa, PhD

Alfred Gilman Professor of Pharmacology and Professor of Medicine (Cardiology); Vice Chairman, Pharmacology; Director, Vascular Biology & Therapeutics Program

Departments & Organizations

Pharmacology: Primary Faculty | Sessa Lab

Cardiovascular Medicine

Cancer Center: Developmental Therapeutics

Developmental Therapeutics

Diabetes Research Center

Faculty Research

Liver Center

NIH T32 Program

Office of Student Research

Skin Diseases Research Center, Yale

Vascular Biology and Therapeutics Program

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development: Cell Biology; Human Disease; Molecular Mechanisms; Proteomics; RNA Biology; Signal Transduction | Molecular Medicine, Pharmacology, and Physiology: Genetics, Genomics and Proteomics; Hematology, Vascular Biology and Inflammation; Receptors and Signal Transduction

Office of Cooperative Research

Education & Training

PhD New York Medical College (1989)
Post-doctoral fellow Pharmacology, The University of Virginia Health Sciences Center
Post-doctoral fellow/Senior Scientist The William Harvey Research Institute

International Activity

  • International Scientific Board London, United Kingdom (2012 - 2017)

    Dr. Sessa is a member of the Scientific Advisory Board to the William Harvey Research Institute [WHRI] and the NIHR Biomedical Research Unit [BRU] in London.

  • YALE-UCL Collaborative London, United Kingdom (2011)

    Dr. Sessa is on the Joint Strategy Committee for the Yale-UCL Collaborative, an alliance which will provide opportunities for high-level scientific research, clinical and educational collaboration across the institutions involved: Yale University, Yale School of Medicine, Yale-New Haven Hospital...

  • Cardiovascular Research United Kingdom (2011)

    Yale-Cambridge Program in Cardiovascular Research that focuses on arteriosclerosis, angiogenisis, vascular injury, and transplantation.

Edit this profile